In the interim, the statutory approvals obtained by the company under SEBI ICDR have lapsed in accordance with applicable law and are required to be re-obtained
The companies anticipate clinical studies to begin in August, subject to regulatory approvals
Oxygen Park is a concept where a two-layer layout is being used to plant oxygen releasing trees which releases oxygen for 24 hours
The company has posted net profit of Rs.12.12 crores for the 12 months period ended March 31, 2021
The company is exploring all legal options to challenge the award.
It is expected that the drug substance would be available from August 2021 which will be supplied back to Bharat Biotech for producing COVAXIN
We focused on developing the product last year but now our focus is on ramping up our manufacturing capacity
Pharma industry is ready to embrace technology platforms with a keen focus on automation in manufacturing and digital health investment.
New Tracxn report highlights growing investor confidence in automated cell therapy production, with Cellares and Ori Biotech dominating funding and regulatory milestones
State-of-the-art facility brings next-generation imaging and minimally invasive neurointerventional capabilities to Eastern India
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
